Zantac Lawsuit: Latest Updates (2025)
Contributor
Reviewed By Adam Ramirez, J.D.
Editor
Summary
- California breast cancer claim joins Florida MDL.
- GSK settled 80,000 claims for a total of $2.2 billion.
- Two Zantac trials proceed in California.
Lawsuit Updates
- California Woman Sues GSK Over Zantac Use
- Mistrial Declared in California Zantac Case
- Zantac Breast Cancer Case Transferred to Florida MDL
Free Zantac Lawsuit Case Review!
By clicking “SUBMIT”, I consent to be contacted by, or on behalf of, ConsumerShield or its trusted legal partners, including for marketing purposes, via the contact information I have provided. I understand that my consent is not a condition of purchasing any goods or services, and that message and data rates may apply. I have the right to opt out of text messages at any time by texting STOP. Additionally, you will be contacted by an attorney.
TRUSTED BY THOUSANDS OF AMERICANS NATIONWIDE |
As seen on:
Zantac Lawsuit Update 2025
Zantac lawsuits continue. New lawsuits claim bladder and breast cancers, which the MDLs did not include originally. However, a California court transferred a breast cancer claim to the MDL in Florida, which shows courts are likely to accept and try these claims.
The first four trials regarding Zantac produced two mistrials and two defendant verdicts. While this news is discouraging, Plaintiffs’ attorneys are hopeful that the upcoming trials will end with better results. Currently, there are two trials in California which appear promising.
An appeal to the Delaware Supreme Court remains pending. Defendants filed the appeal claiming that the expert opinions fail to meet a clear threshold on when ranitidine becomes a cancer risk. They argue for a “nuanced” approach with Delaware law that considers broader scientific evidence and the complexities of chemical exposure injuries.
Meanwhile, defendants continue settling stronger claims against them. GSK recently joined this list by agreeing to settle 80,000 claims for $2.2 billion.
Basis of the Zantac Lawsuit
Heartburn occurs when stomach acid flows backward into the esophagus. Medical professionals also call it acid reflux or GERD (gastroesophageal reflux disease). Approximately 15 million Americans suffer heartburn every day.
Patients can treat heartburn with H2 blocks or proton pump inhibitors, both of which reduce the amount of acid made by the stomach. Zantac, Tagamet, Pepcid AC, and Axid are H2 blockers.
The problem with Zantac is one of its ingredients, ranitidine, can break down and form N-nitrosodimethylamine (NDMA), a carcinogen linked to cancer. Once discovered, the FDA determined Zantac was dangerous and ordered it off the market. Laboratory studies reveal even small amounts of NDMA can cause liver, lung and kidney cancer.
Zantac lawsuit plaintiffs include individuals who used Zantac for years and developed terminal cancers, including:
- Stomach
- Liver
- Pancreatic
- Esophageal
- Pharyngeal
- Breast
- Bladder
- Colorectal
Defendants in these lawsuits include Zantac manufacturers, GlaxoSmithKline (GSK), Pfizer, Sanofi and Boehringer Ingelheim.
Procedural Posture of the Zantac Cancer Lawsuit
Plaintiffs allege defendants failed to warn consumers about the NDMA contamination risk. They also include other product liability claims like negligence in testing, marketing and distributing Zantac.
Zantac lawsuits involve individuals, class action and MDL lawsuits. Individual lawsuits only involve the injured plaintiff and the manufacturer. Their main advantage is if a jury awards damages to a plaintiff, they retain the entire amount. The two cases proceeding in California are individuals lawsuits.
Class action lawsuits involve multiple plaintiffs in the same case. Rather than acting as individuals, the plaintiffs act and make decisions as a “class.” Class members have claims and losses in common. A representative makes decisions on behalf of the entire class. This arrangement allows litigants to share expenses, but they share settlements and may receive lower damage awards.
MDLs help courts organize similar actions. The lawsuits remain separate, but the court applies the same rules to all the cases regarding discovery and motions. Plaintiffs and lawyers often must consolidate information and cooperate to keep the cases moving forward. This arrangements makes managing the cases more efficient.
There are MDLs in Florida and Delaware, and a class action lawsuit in California.
ConsumerShield Can Help Zantac Consumers
There is still time to file your Zantac lawsuit, even with the latest settlements and trials. ConsumerShield can help you understand your legal rights and connect you with a lawyer to represent you against these massive drug companies. Contact us for a free case evaluation.
Zantac Lawsuit Knowledge Base
Read the latest information on Zantac Lawsuit and find answers to your questions. Currently there are 3 topics about Zantac Lawsuit Lawsuits.
Updates
Settlements & Payouts
Frequently Asked Questions
-
Yes, several lawsuits against the manufacturers of Zantac remain ongoing. One federal multidistrict litigation in Delaware just passed an important milestone when the judge allowed testimony by the plaintiff’s expert witnesses. Manufacturers also face several state class action lawsuits.
-
Zantac’s manufacturers have not entered into a global settlement to resolve all the outstanding injury claims. Thus, there is no way to predict which cancers will qualify for a settlement. Lawyers are also still alleging diverse injuries. However, settlement discussions seem to focus on bladder, stomach, esophageal, liver and pancreatic cancers.
-
You will need evidence of several facts, including the following:
- You took Zantac regularly.
- You developed cancer within a reasonable time after taking it.
- Your finances or quality of life suffered as a result of your cancer.
Your lawyer will advise you about the documents you need to prove each of these elements.
